XNAS · Healthcare · Biotechnology
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.40 | -0.41 | -2.50% | $350,000 | ❌ Miss | -1.01% | +0.91% | — |
| 2026-05-05 | Q1 2026 | -0.36 | -0.41 | -13.89% | $3.0M | ❌ Miss | -0.67% | -0.54% | +11.85% |
| 2026-02-26 |
| Q4 2025 |
| -0.39 |
| -0.32 |
| +17.95% |
| $7.0M |
| ✅ Beat |
| +3.71% |
| +5.24% |
| +4.80% |
| 2025-11-06 | Q3 2025 | -0.41 | -0.43 | -4.88% | $0 | ❌ Miss | — | — | — |
| 2025-08-07 | Q2 2025 | -0.48 | -0.41 | +14.58% | $677,000 | ✅ Beat | -4.80% | -2.87% | +18.05% |
| 2025-02-26 | Q4 2024 | -0.55 | -0.45 | +18.18% | $0 | ✅ Beat | -13.33% | -9.60% | -27.47% |
| 2024-11-06 | Q3 2024 | -0.77 | -0.63 | +18.18% | $0 | ✅ Beat | -1.76% | -7.04% | -26.24% |
| 2024-08-06 | Q2 2024 | -0.73 | -0.69 | +5.48% | $0 | ✅ Beat | -7.93% | -8.76% | -9.74% |
Showing last 8 quarters.